Product Code: GVR-4-68040-125-5
Intravascular Stents Market Growth & Trends:
The global intravascular stents market size is expected to reach USD 22.69 billion by 2030, according to a new report by Grand View Research, Inc.., registering a CAGR of 8.0% from 2023 to 2030. The growth of the market can be attributed to the increasing prevalence of peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). According to the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) accounted for approximately 19.05 million deaths worldwide.
Additionally, cerebrovascular diseases were responsible for approximately 7.08 million deaths globally during the same year. These alarming statistics underscore the significant burden of cardiac diseases and emphasize the urgent need for effective interventions, such as intravascular stents. The demand for these medical devices is driven by the necessity to address the rising incidence of PVDs and CAD and to provide patients with enhanced treatment options for better cardiovascular outcomes. As a result, intravascular stents play a critical role in managing and treating these prevalent cardiovascular conditions, contributing to the growth of the market.
The increasing prevalence of coronary artery diseases (CADs), which occur when plaque accumulates in the arteries, has led to a growing demand for percutaneous coronary intervention treatments involving stents. This surge in demand is expected to be the primary driver fueling the expansion of the coronary stent market. According to a report released in February 2022 by the Heart and Stroke Foundation of Canada, approximately 750,000 individuals in the country live with heart failure, and around 100,000 new cases are diagnosed annually.
By 2030, the healthcare costs associated with heart failure in Canada are projected to reach up to USD 2.8 billion annually. Consequently, the market for intravascular stents is anticipated to experience rapid growth throughout the forecast period due to the significant number of cardiac patients and the increasing economic burden caused by heart failure in the nation. Furthermore, the market is expected to be supported by the rising prevalence of CAD risk factors, including age, hypertension, diabetes, and others, during the projection period.
Intravascular Stents Market Segmentation:
- The drug-eluting stents (DES) segment dominated the market in 2022, holding the largest share of 58.22%. DES has proven efficacy in reducing restenosis compared to bare metal stents (BMS) and offers a lower incidence of major adverse cardiac events (MACE)
- The balloon-expanding stents segment also held a significant share of 53.91% in the market in 2022. Balloon-expanding stents provide a notable advantage by enabling precise and controlled expansion within the affected blood vessel. The segment's growth is further fueled by the increasing preference for minimally invasive procedures
- In 2022, the coronary stents segment held the largest market share at 77.46%. The rising prevalence of coronary artery diseases (CADs) and the growing demand for percutaneous coronary intervention treatments are driving the expansion of this segment
- In 2022, the hospital & cardiac centers segment dominated the market, representing the largest share of 74.55%. These specialized medical facilities play a crucial role in diagnosing and treating a wide range of cardiovascular diseases, including conditions related to peripheral arterial disease
- North America emerged as the leading market region in 2022, holding the largest share of 43.79%. The region's robust healthcare infrastructure, advanced medical facilities, and skilled healthcare professionals contribute to the easy accessibility of peripheral vascular stents for patients in the region
- Key market players include Boston Scientific Inc., Medtronic, Terumo Medical, Abbott, Biotronik, Lifetech, iVascular SLU, Stryker, Cook Medical, Microport Scientific Corporation, Stentys S.A., Hellman & Friedman (Cordis Inc.), B Braun Melsungen AG
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Commodity Flow Analysis
- 1.5.1.1. Approach 1: Commodity flow approach
- 1.6. Data Validation & Publishing
- 1.7. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.4. Market Restraint Analysis
- 3.5. Business Environment Analysis
- 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
- 3.5.2. Porter's Five Forces Analysis
- 3.6. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
- 4.1. Intravascular Stents Market, By Type: Key Takeaways
- 4.2. Intravascular Stents Market: Type Movement & Market Share Analysis, 2022 & 2030
- 4.3. Drug Eluting Stents (DES)
- 4.3.1. Global Drug Eluting Stents (DES) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Bare Metal Stents (BMS)
- 4.4.1. Global Bare Metal Stents (BMS) Intravascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Bioabsorbable Stents
- 4.5.1. Global Bioabsorbable Stents Intravascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Mode of Delivery Business Analysis
- 5.1. Intravascular Stents Market, By Mode of Delivery: Key Takeaways
- 5.2. Intravascular Stents Market: Mode of Delivery Movement & Market Share Analysis, 2022 & 2030
- 5.3. Self-expanding Stents
- 5.3.1. Global Coronary Artery Bypass Grafting (CABG) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Balloon-expandable Stents
- 5.3.2.1. Global Balloon-expandable Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Product Business Analysis
- 6.1. Intravascular Stents Market, By Product: Key Takeaways
- 6.2. Intravascular Stents Market: Product Movement & Market Share Analysis, 2022 & 2030
- 6.3. Coronary Stents
- 6.3.1. Global Coronary Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Peripheral Stents
- 6.4.1. Global Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.1.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.2. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.2.1. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.3. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.3.1. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.4. Global Renal Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.4.1. Global Renal Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.5. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.1.5.1. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Neurovascular Stents
- 6.4.2.1. Global Neurovascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.2. Global Intracranial Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.2.1. Global Intracranial Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.3. Global Flow Diverters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.3.1. Global Flow Diverters Market Estimates and Forecasts, 2018 - 2030 (USD Million
Chapter 7. End-Use Business Analysis
- 7.1. Intravascular Stents Market, By End Use: Key Takeaways
- 7.2. Intravascular Stents Market: End Use Movement & Market Share Analysis, 2022 & 2030
- 7.3. Hospitals & Cardiac Centers
- 7.3.1. Global Hospitals & Cardiac Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. Global Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Others
- 7.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Regional Market Snapshot
- 8.2. Market Share Analysis by Country, 2022
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. MEA
- 8.3. North America
- 8.3.1. North America Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. U.S. Intravascular Stents Market, 2018 - 2030 (USD MILLION)
- 8.3.3. Canada
- 8.3.3.1. Canada Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Germany Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.3. UK
- 8.4.3.1. UK Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. France Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Italy Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Spain Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Denmark Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Sweden Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Norway Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Japan Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.3. China
- 8.5.3.1. China Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. India Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. South Korea Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Australia Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Thailand Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Brazil Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.6.3. Mexico
- 8.6.3.1. Mexico Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.6.4. Argentina
- 8.6.4.1. Argentina Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.7. MEA
- 8.7.1. MEA Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. South Africa Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Saudi Arabia Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. UAE Intravascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Kuwait Intravascular Stents Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.3. Company Profiles/Listing
- 9.3.1. Medtronic
- 9.3.1.1. Overview
- 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.1.3. Product Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Terumo Europe NV
- 9.3.2.1. Overview
- 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.2.3. Product Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Boston Scientific Inc.
- 9.3.3.1. Overview
- 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.3.3. Product Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Stryker
- 9.3.4.1. Overview
- 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Biotronik
- 9.3.5.1. Overview
- 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Cook Medical
- 9.3.6.1. Overview
- 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Microport Scientific Corporation
- 9.3.7.1. Overview
- 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.7.3. Product Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Lifetech
- 9.3.8.1. Company Overview
- 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.8.3. Platform Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. iVascular SLU
- 9.3.9.1. Company Overview
- 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.9.3. Platform Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. Hellman & Friedman (Cordis Inc.)
- 9.3.10.1. Company Overview
- 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.10.3. Platform Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.11. Stentys S.A.
- 9.3.11.1. Company Overview
- 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.11.3. Platform Benchmarking
- 9.3.11.4. Strategic Initiatives